Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).
Ziemssen T, Engelmann U, Jahn S, Leptich A, Kern R, Hassoun L, Thomas K
